Differences

This shows you the differences between two versions of the page.

--- home:diseases:cancer [04.19.2019] – [Vitamin D] sallieq
+++ home:diseases:cancer [04.26.2019] – [Are There Concerns About V.D Supplement ?] sallieq
@@ Line 23: / Line 23: @@
   * **liver cancer** – It is "well established" that chronic infections with hepatitis B and C viruses (HBV, HCV) represent major risk factors for HCC.(({{pubmed>long:10710202}}))
   * **lung cancer** – According to a 2011 meta-analysis, patients exposed to //C. pneumoniae// infection had a 48% greater risk for lung cancer risk, relative to those not exposed.(({{pubmed>long:21194924}}))
   * **prostate cancer** – In a 2005 culture-based study, Cohen found that //Propionibacterium acnes// in 35% of prostate samples of 34 consecutive patients tested.(({{pubmed>long:15879794}}))
+  * **Table of cancers** with associated agents. [[https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-017-3234-4|Infections and Cancer]]
@@ Line 87: / Line 88: @@
 Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis. (({{pubmed>long:30718230}}))
+  a Cochrane meta-analysis that included 18 randomized clinical trials comparing vitamin D administration versus no intervention in healthy population found no difference regarding cancer incidence.  In randomised controlled trials, relative risks for all cause mortality were 0.89 (0.80 to 0.99) for vitamin D3 supplementation and 1.04 (0.97 to 1.11) for vitamin D2 supplementation. The effects observed for vitamin D3 supplementation remained unchanged when grouped by various characteristics. However, for vitamin D2 supplementation, increased risks of mortality were observed in studies with lower intervention doses and shorter average intervention periods.  (({{pubmed>long:    24690623}}))
 ====1,25-dihydroxyvitamin D ====

home/diseases/cancer.txt · Last modified: 09.14.2022 by 127.0.0.1